Trans-arterial chemo-embolization is safe and effective for elderly advanced hepatocellular carcinoma patients: results from an international database. (Q53095390)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Trans-arterial chemo-embolization is safe and effective for elderly advanced hepatocellular carcinoma patients: results from an international database.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24512125%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Trans-arterial chemo-embolization is safe and effective for elderly advanced hepatocellular carcinoma patients: results from an international database (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24512125%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

0 references

Massimo Di Maio

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24512125%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24512125%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

Matan J Cohen

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24512125%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Izhar Levy

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24512125%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Orly Barak

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24512125%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Allan I Bloom

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24512125%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Mario Fernández-Ruiz

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24512125%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Francesco Perrone

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24512125%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Ronnie T Poon

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24512125%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Daniel Shouval

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24512125%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Oren Shibolet

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24512125%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

publication date

4 April 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24512125%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Liver International

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24512125%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

34

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24512125%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24512125%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1109-1117

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24512125%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12486

21 January 2018

The changing pattern of epidemiology in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12486

21 January 2018

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12486

21 January 2018

Management of hepatocellular carcinoma: An update

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12486

21 January 2018

Liver transplantation in the United States, 1999-2008.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12486

21 January 2018

Clinical features and prognosis of hepatocellular carcinoma in Britain in relation to age.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12486

21 January 2018

Long-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma undergoing hepatectomy

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12486

21 January 2018

A comparative analysis of hepatocellular carcinoma after hepatic resection in young versus elderly patients

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12486

21 January 2018

Hepatectomy for hepatocellular carcinoma in elderly patients aged 75 years or more

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12486

21 January 2018

The outcomes of elderly patients with hepatocellular carcinoma treated with transarterial chemoembolization.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12486

21 January 2018

Optimal treatment strategy for elderly patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12486

21 January 2018

Hepatocellular carcinoma in extremely elderly patients: an analysis of clinical characteristics, prognosis and patient survival

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12486

21 January 2018

Trans-arterial chemo-embolization is safe and effective for very elderly patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12486

21 January 2018

Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12486

21 January 2018

Prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12486

21 January 2018

Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12486

21 January 2018

Hepatocellular carcinoma in older adults: clinical features, treatments, and survival

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12486

21 January 2018

Transcatheter arterial chemoembolisation for hepatocellular carcinoma in cirrhosis: survival rate and prognostic factors

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12486

21 January 2018

Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12486

21 January 2018

Transarterial chemoembolization in very early and early-stage hepatocellular carcinoma patients excluded from curative treatment: a prospective cohort study.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12486

21 January 2018

Factors associated with the overall survival of elderly patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12486

21 January 2018

Prospective evaluation of the management of hepatocellular carcinoma in the elderly.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12486

21 January 2018

A multicenter retrospective study on clinical characteristics, treatment patterns, and outcome in elderly patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12486

21 January 2018

The outcomes and safety of single-agent sorafenib in the treatment of elderly patients with advanced hepatocellular carcinoma (HCC).

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12486

21 January 2018

Younger hepatocellular carcinoma patients have better prognosis after percutaneous radiofrequency ablation therapy.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12486

21 January 2018

Review on transarterial chemoembolization in hepatocellular carcinoma: palliative, combined, neoadjuvant, bridging, and symptomatic indications

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12486

21 January 2018

Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12486

21 January 2018

Pretreatment assessment of hepatocellular carcinoma: expert consensus statement

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12486

21 January 2018

Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12486

21 January 2018

Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12486

21 January 2018

Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20-year multicentre experience

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12486

21 January 2018

Identifiers

10.1111/LIV.12486

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24512125%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24512125%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53095390&oldid=1131158233"